Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization

Molecular and Cellular Biology

Volumn 19, Issue 2, 1999, Pages 1002-1015

  Chen, Dongsheng ^a   Pace, Paul E ^a   Coombes, R Charles ^a   Ali, Simak ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT;

ANIMAL CELL; ARTICLE; DIMERIZATION; HUMAN; LIGAND BINDING; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

ANIMALIA;

EID: 0032906876     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.2.1002     Document Type: Article

References (89)

1. Ali, S., D. Metzger, J.-M. Bornert, and P. Chambon. 1993. Phosphorylation of the human oestrogen receptor: identification of a phosphorylation site required for trans-activation. EMBO J. 12:1153-1160.
2. Ali, S., Y. Lutz, J.-P. Bellocq, M.-P. Chenard-Neu, N. Rouyer, and D. Metzger. 1993. Production and characterisation of monoclonal antibodies recognising defined regions of the human oestrogen receptor. Hybridoma 12:391-405.
3. Arnold, S. F., J. D. Obourn, H. Jaffe, and A. C. Notides. 1994. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol. 8:1208-1214.
4. Arnold, S. F., J. D. Obourn, H. Jaffe, and A. C. Notides. 1995. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J. Steroid Biochem. Mol. Biol. 55:163-172.
5. Arnold, S. F., J. D. Obourn, M. R. Yudt, T. H. Carter, and A. C. Notides. 1995. In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Mol. Biol. 52:159-171.
6. Arnold, S. F., J. D. Obourn, H. Jaffe, and A. C. Notides. 1995. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol. Endocrinol. 9:24-33.
7. Arnold, S. F., D. P. Vorojeikina, and A. C. Notides. 1995. Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J. Biol. Chem. 270:30205-30212.
8. Arnold, S. F., M. Melamed, D. P. Vorojeikina, A. C. Notides, and S. Sasson. 1997. Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation. Mol. Endocrinol. 11:48-53.
9. Aronica, S. M., and B. S. Katzenellenbogen. 1993. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclin adenosine monophosphate and insulin-like growth factor-1. Mol. Endocrinol. 7:743-752.
10. Auricchio, F. 1989. Phosphorylation of steroid receptors. J. Steroid Biochem. 32:613-622.
11. Bai, W., and N. L. Weigel. 1996. Phosphorylation of Ser-211 in the chicken progesterone receptor modulates its transcriptional activity. J. Biol. Chem. 271:12801-12806.
12. Beato, M. 1989. Gene regulation by steroid hormones. Cell 56:335-344.
13. Beato, M., P. Herlich, and G. Schutz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
14. Berry, M., D. Metzger, and P. Chambon. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:2811-2818.
15. Berthois, Y., J. A. Katzenellenbogen, and B. S. Katzenellenbogen. 1986. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 89:1218-1222.
16. Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-148.
17. Brzozowski, A. M., A. C. W. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G. L. Green, J.-A. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism of the oestrogen receptor. Nature 389:753-758.
18. Budhram-Mahadeo, V., M. Parker, and D. S. Latchman. 1998. POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol. Cell. Biol. 18:1029-1041.
19. Bunone, G., P.-A. Briand, R. J. Miksicek, and D. Picard. 1996. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:2174-2183.
20. Castoria, G., A. Migliaccio, S. Green, M. Di-Domenico, P. Chambon, and F. Aurrichio. 1993. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry 32:1740-1750.
21. Cho, H., and B. S. Katzenellenbogen. 1993. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7:441-152.
22. Cowley, S. M., S. Hoare, S. Mosselman, and M. G. Parker. 1997. Estrogen receptor α and β form heterodimers on DNA. J. Biol. Chem. 272:19858-19862.
23. Dauvois, S., P. S. Danielian, R. White, and M. G. Parker. 1993. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci. 103:1377-1388.
24. Dauvois, S., P. S. Danielian, R. White, and M. G. Parker. 1992. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA 89:4037-4041.
25. DeFranco, D. B., M. Qi, K. C. Boffor, M. J. Garabedian, and D. L. Brautigan. 1991. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol. Endocrinol. 5:1215-1528.
26. El-Tanani, M. K., and C. D. Green. 1997. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol. Endocrinol. 11:928-937.
27. Fawell, S. E., R. White, S. Hoare, M. Sydenham, M. Page, and M. G. Parker. 1990. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA 8:6883-6887.
28. Gaub, M.-P., M. Bellard, I. Scheuer, P. Chambon, and P. Sassone-Corsi. 1990. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63:1267-1276.
29. Gibson, M. K., L. A. Nemmers, W. C. Beckman, V. L. Davis, S. W. Curtis, and K. S. Korach. 1991. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129:2000-2010.
30. Gilbert, D. M., R. Losson, and P. Chambon. 1992. Ligand dependence of estrogen receptor induced changes in chromatin structure. Nucleic Acids Res. 20:4525-4531.
31. Glineur, C., M. Zenke, H. Beug, and J. Ghysdael. 1990. Phosphorylation of the v-erbA protein is required for its function as an oncogene. Genes Dev. 4:1663-1676.
32. Goldberg, Y., C. Glineur, J. C. Gesquiere, A. Ricouart, J. Sap, B. Vennstrom, and J. Ghysdael. 1988. Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein. EMBO J. 7:2425-2433.
33. Green, S., I. Isseman, and E. Sheer. 1988. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 10:369-370.
34. Gronemeyer, H. 1991. Transcription activation by estrogen and progesterone receptors. Annu. Rev. Biochem. 25:89-123.
35. Hidaka, H., M. Watanabe, and R. Kobayashi. 1991. Properties and use of H-series compounds as protein kinase inhibitors. Methods Enzymol. 201: 328-339.
36. Hsieh, J.-C., P. W. Jurutka, M. A. Galligan, C. M. Terpenning, C. A. Haussler, D. S. Samuels, Y. Shimizu, N. Shimizu, and M. R. Haussler. 1991. Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site. Proc. Natl. Acad. Sci. USA 88:9315-9319.
37. Hsieh, J.-C., P. W. Jurutka, N. Shigeo, M. A. Galligan, C. A. Haussler, Y. Shimizu, N. Shimizu, G. K. WhitHeld, and M. R. Haussler. 1993. Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its transactivation function. J. Biol. Chem. 268:15118-15126.
38. Hsu, S. C., and D. B. de Franco. 1995. Selectivity of cell cycle regulation of glucocorticoid receptor function. J. Biol. Chem. 270:3359-3364.
39. Hu, J. M., J. E. Bodwell, and A. Munck. 1994. Cell cycle-dependent glucocorticoid receptor phosphorylation and activity. Mol. Endocrinol. 8:1709-1713.
40. Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375-387.
41. Ignar-Trowbridge, D., C. T. Teng, K. A. Ross, M. G. Parker, K. S. Korach, and J. A. McLachlan. 1993. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7:992-998.
42. Ince, B. A., M. M. Montano, and B. S. Katzenellenbogen. 1994. Activation of transcriptionally inactive human estrogen receptors by cyclin adenosine 3′,5′-monophosphate and ligands including antiestrogens. Mol. Endocrinol. 8:1397-1406.
43. Jackson, S. P. 1992. Regulating transcription factor activity by phosphorylation. Trends Cell Biol. 2:104-108.
44. Joel, P. B., A. M. Traish, and D. A. Lannigan. 1995. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol. Endocrinol. 9:1041-1052.
45. Joel, P. B., J. Smith, T. W. Sturgill, T. L. Fisher, J. Blenis, and D. A. Lannigan. 1998. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18:1978-1984.
46. Karin, M. 1994. Signal transduction from the cell surface to the nucleus through phosphorylation of transcription factors. Curr. Opin. Cell Biol. 6:415-424.
47. Kato, S., E. Endoh, Y. Masuhira, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, D. Metzger, and P. Chambon. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
48. Kladde, M. P., M. Xu, and R. T. Simpson. 1996. Direct study of DNA-protein interactions in repressed and active chromatin in living cells. EMBO J. 15:6290-6300.
49. Krust, A., S. Green, P. Argos, V. Kumar, P. Walter, J.-M. Bornert, and P. Chambon. 1986. The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J. 5:891-897.
50. Kumar, V., S. Green, A. Staub, and P. Chambon. 1986. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J. 5:2231-2236.
51. Kumar, V., S. Green, G. Stack, M. Berry, J. R. Jin, and P. Chambon. 1987. Functional domains of the human estrogen receptor. Cell 51:941-951.
52. Lees, J. A., S. E. Fawell, and M. G. Parker. 1989. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 17:5477-5488.
53. Le Goff, P., M. M. Montano, D. J. Schodin, and B. S. Katzenellenbogen. 1994. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:4458-4466.
54. Ma, Z. Q., S. Santagati, C. Patrone, G. Pollio, E. Vegeto, and A. Maggi. 1994. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastorna cell line SK-ER3. Mol. Endocrinol. 8:910-918.
55. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
56. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Hefflich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 8:835-839.
57. McDonnell, D. P., D. L. Clemm, T. Hermann, M. E. Goldman, and J. W. Pike. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:659-669.
58. McInerney, E. M., and B. S. Katzenellenbogen. 1996. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 271: 24172-24178.
59. Metzger, D., S. Ali, J.-M. Bornert, and P. Chambon. 1995. Characterization of the N-terminal transcriptional activation function (AF-1) of the human oestrogen receptor in animal and yeast cells. J. Biol. Chem. 270:9535-9542.
60. Metzger, D., M. Berry, S. Ali, and P. Chambon. 1995. Effect of antagonists on DNA binding properties of the human oestrogen receptor in vitro and in vivo. Mol. Endocrinol. 9:579-591.
61. Newton, C. J., R. Buric, T. Trapp, S. Brockmeier, U. Pagotto, and G. K. Stalla. 1994. The unliganded estrogen receptor (ER) transduces growth factor signals. J. Steroid Biochem. Mol. Biol. 48:481-486.
62. Ogawa, S., S. Inoue, T. Watanabe, H. Hiroi, A. Orimo, T. Hosoi, Y. Ouchi, and M. Muramatsu. 1998. The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerization with ERα in vivo and in vitro. Biochem. Biophys. Res. Commun. 243:122-126.
63. Pace, P. E., J. Taylor, S. Suntharalingam, R. C. Coombes, and S. Ali. 1997. Human estrogen receptor beta binds DNA in a manner similar to and dimerises with estrogen receptor alpha. J. Biol. Chem. 272:25832-25838.
64. Patrone, C., Z. Q. Ma, G. Pollio, P. Agrati, M. G. Parker, and A. Maggi. 1996. Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol. Endocrinol. 10:499-507.
65. Pettersson, K., K. Grandien, G. G. Kuiper, and J. A. Gustafsson. 1997. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol. Endocrinol. 11:1486-1496.
66. Pham, T. A., J. F. Elliston, Z. Nawaz, D. P. McDonnell, M.-J. Tsai, and B. W. O'Malley. 1991. Antiestrogens can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. Proc. Natl. Acad. Sci. USA 88:3125-3129.
67. Philipsen, J. N. J., B. C. Hennis, and G. Ab. 1988. In vivo footprinting of the estrogen-inducible vitellogenin II gene from chicken. Nucleic Acids Res. 16:9663-9676.
68. Pietras, R. J., J. Arboleda, D. M. Reese, N. Wongvipat, M. D. Pelgram, L. Ramos, C. M. Gorman, M. G. Parker, M. X. Sliwkowski, and D. J. Slamon. 1995. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2446.
69. Power, R. F., S. K. Mani, J. Codina, O. M. Conneely, and B. W. O'Malley. 1991. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254:1636-1639.
70. Ray, A., K. E. Prefontaine, and P. Ray. 1994. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269:12940-12946.
71. Reese, J. C., and B. S. Katzenellenbogen. 1992. Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens. Mol. Cell. Biol. 12:4531-4538.
72. Rochette-Egly, C., S. Adam, M. Rossignol, J.-M. Egly, and P. Chambon. 1997. Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFI1H and phosphorylation by CDK7. Cell 90: 97-107.
73. Rochette-Egly, C., M. Oulad-Abdelghani, A. Staub, V. Pfister, I. Scheuer, P. Chambon, and M.-P. Gaub. 1995. Phosphorylation of the retinoic acid receptor a by protein kinase A. Mol. Endocrinol. 9:860-871.
74. Saha, S., J. M. Brickman, N. Lehming, and M. Ptashne. 1993. New eukaryotic transcriptional repressors. Nature 363:648-652.
75. Schwabe, J. W. R. Personal communication.
76. Schwabe, J. W. R., L. Chapman, J. T. Finch, and D. Rhodes. 1993. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 70:567-578.
77. Stein, B., and M. X. Yang. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C-EBP beta. Mol. Cell. Biol. 15:4971-4979.
78. Takimoto, G. S., A. R. Hovland, D. M. Tasset, M. Y. Melville, L. Tung, and K. B. Horwitz. 1996. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J. Biol. Chem. 271: 13308-13316.
79. Tora, L., A. Mullick, D. Metzger, M. Ponglikitmongkol, I. Park, and P. Chambon. 1989. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8:1981-1986.
80. Tora, L., J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon. 1989. The human estrogen receptor has two independent non-acidic transcriptional activation functions. Cell 59:477-487.
81. Tremblay, G. B., A. Tremblay, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, F. Labrie, and V. Giguere. 1997. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β. Mol. Endocrinol. 11:353-365.
82. Tremblay, A., G. B. Tremblay, C. Labrie, F. Labrie, and V. Giguere. 1998. EM800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors α and β. Endocrinology 139:111-118.
83. Truss, M., and M. Beato. 1993. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev. 14:459-479.
84. Tsai, M. J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid/receptor superfamily members. Annu. Rev. Biochem. 63: 451-486.
85. Webster, N. J. G., S. Green, J. R. Jin, and P. Chambon. 1988. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54:199-207.
86. Weis, K. E., K. Ekena, J. A. Thomas, G. Lazenneac, and B. S. Katzenellenbogen. 1996. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10:1388-1398.
87. White, R., M. Sjoberg, E. Kalkhoven, and M. G. Parker. 1997. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 16:1427-1435.
88. Wijnholds, J., J. N. J. Philipsen, and G. Ab. 1988. Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-inducible apoVLDL II promoter in vivo. EMBO J. 7:2757-2763.
89. Zhang, Y., C. A. Beck, A. Poletti, J. P. Clement IV, P. Prendergast, T.-Y. Yip, T. W. Hutchens, D. P. Edwards, and N. L. Weigel. 1997. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol. Endocrinol. 11:823-832.